Atlas Trials

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Clinical trial NCT05486988 · UNKNOWN

Trial details

NCT number
NCT05486988
Sponsor
Fuzhou General Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer
Start date
2022-07-31
Primary completion
2024-06-30
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.